PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAC8. A total of 17 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $17,779,000 | +3.7% | 13,446,000 | 0.0% | 0.85% | -14.8% |
Q3 2014 | $17,142,000 | -20.4% | 13,446,000 | 0.0% | 1.00% | -26.6% |
Q2 2014 | $21,531,000 | +23.7% | 13,446,000 | +5.5% | 1.36% | +51.1% |
Q1 2014 | $17,400,000 | -26.3% | 12,751,000 | -26.5% | 0.90% | -12.9% |
Q4 2013 | $23,595,000 | +6.8% | 17,350,000 | 0.0% | 1.04% | +4.7% |
Q3 2013 | $22,103,000 | +2.8% | 17,350,000 | 0.0% | 0.99% | +1.4% |
Q2 2013 | $21,507,000 | – | 17,350,000 | – | 0.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 20,750,000 | $25,781,000 | 3.35% |
Sage Capital Management, LLC | 2,500,000 | $3,092,000 | 3.23% |
WHITEBOX ADVISORS LLC | 24,874,000 | $30,844,000 | 1.62% |
Castle Creek Arbitrage, LLC | 17,350,000 | $21,507,000 | 0.98% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 4,598,000 | $5,673,000 | 0.52% |
WOLVERINE ASSET MANAGEMENT LLC | 15,690,000 | $19,386,000 | 0.50% |
AMUNDI ASSET MANAGEMENT US, INC. | 25,195,000 | $31,084,000 | 0.13% |
Cutler Capital Management, LLC | 237,000 | $292,000 | 0.13% |
PALISADE CAPITAL MANAGEMENT, LP | 3,500,000 | $4,371,000 | 0.13% |
LAZARD ASSET MANAGEMENT LLC | 14,457,000 | $17,836,000 | 0.04% |